Journal of Endourology · 2001 · 27 citations · 19 references
MedicineCardiologyHematologyCardiovascular PharmacotherapyHemostasisVascular SurgeryAnticoagulant TherapyAnticoagulation TherapyAntiplatelet TherapyAntithrombotic TherapyShock Wave LithotripsyThrombosisAntiplatelet DrugsElectromagnetic LithotripsyPerioperative Antiplatelet TherapyThromboembolic Risk Stratification
PATIENTS AND METHODS: Between January 1996 and December 1999, 749 patients underwent electromagnetic SWL. Among them, 23 patients, 19 with renal and 4 with ureteral stones, were receiving antithrombotic drugs (aspirin, ticlopidine, dipyridamole). According to the cardiologist and hematologist, we divided these patients into two groups: Group 1 had a low thromboembolic risk (previous myocardial infarction), and Group 2 had a high thromboembolic risk (aortocoronary bypass, atrial fibrillation, cerebrovascular disease, peripheral occlusive arterial disease). Group 1 patients discontinued their antiplatelet therapy 8 days prior to SWL to permit a sufficient number of functioning platelets to remain. Group 2 patients suspended antiplatelet therapy, and unfractioned heparin 5000 IU tid (8 a.m., 4 p.m., and 12 p.m.) was administered for the 8 days prior to SWL. On the ninth day of withdrawal, SWL was performed in all patients. Close follow-up was performed during the postoperative period (hemoglobin, hematocrit, kidney ultrasonography, plain abdominal film). The antithrombotic therapy was restored in all patients within 10 to 14 days of withdrawal. RESULTS: Hematomas and thromboembolic events were not observed. At 3 months' follow-up, 14 patients (61%) were stone free, 3 (13%) had <4-mm fragments, and 6 (26%) had >4-mm residual fragments. CONCLUSION: Our schedules for the suspension or substitution of antithrombotic therapy, although tested in a small number of patients, allowed us to perform SWL without hemorrhagic or thromboembolic complications.
19
Platelet Sequestration in Man. I. Methods*
Richard H. Aster, James H. Jandl · Journal of Clinical Investigation · 1964 · 819 citations · Full text
Renal morphology and function immediately after extracorporeal shock-wave lithotripsy
JV Kaude, CM. Williams, MR Millner et al. · American Journal of Roentgenology · 1985 · 393 citations
Medicine, Nephrology, Surgery +15
Extracorporeal shock-wave lithotripsy (ESWL) for treatment of urolithiasis
C. Chaussy, E Schmiedt, D. Jocham et al. · Urology · 1984 · 338 citations
Kidney changes after extracorporeal shock wave lithotripsy: CT evaluation.
Joan Rubin, Peter H. Arger, HM Pollack et al. · Radiology · 1987 · 215 citations